Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

Delayed Quote. Delayed  - 07/22 10:00:00 pm
132.55 USD   +0.45%
07/15 BLACKROCK INSTI : Boosts Stake in Ligand Pharmaceuticals Inc.
07/14 LIGAND PHARMACE : to Report Second Quarter Results on August 4th
07/09 LIGAND PHARMACE : Enters into OmniAb Platform License Agreement with..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CEST

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
07/15 BLACKROCK INSTITUTIONAL TRUST COMPAN : Boosts Stake in Ligand Pharmaceuticals In..
07/14 LIGAND PHARMACEUTICALS : to Report Second Quarter Results on August 4th
07/09 LIGAND PHARMACEUTICALS : Enters into OmniAb Platform License Agreement with Gile..
07/08 LIGAND PHARMACEUTICALS : Enters into OmniAb® Platform License Agreement with Gil..
07/02 LIGAND PHARMACEUTICALS : Receives $4 Million from Expansion of Two OmniAb Licens..
07/02 LIGAND PHARMACEUTICALS INCORPORATED : Receives $4 Mln from : Violin Memory, Xer..
06/30 LIGAND PHARMACEUTICALS : Receives $4 Million from Expansion of Two OmniAb® Licen..
05/25 LIGAND PHARMACEUTICALS INC : Change in Directors or Principal Officers, Submissi..
05/16 LIGAND PHARMACEUTICALS : Intec Pharma to Nominate Dr. John W. Kozarich as Chairm..
05/12 LIGAND PHARMACEUTICALS : Patent Issued for Nucleotide Prodrug Compounds and Use ..
More news
Sector news : Biotechnology & Medical Research - NEC
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/21 Ligand Pharma - Expands Partnerships With OMT Acquisition
07/07 21 Stocks For July 2016
07/06 Biotechnology - The Perfect Yo-Yo
07/01 The Stock Market Is Not Ready To Give Up
06/03 BIOTECHNOLOGY : Ready To Move Higher - Much Higher